- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04022369
The Effects of an Exercise Programme for Older Patients With Heart Failure
The Effects of an Exercise Empowerment Programme for Older Patients With Heart Failure: A Randomized Controlled Trial
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Patients with heart failure have decreased exercise tolerance, balance problems, and fall risks. The purpose of this research was to investigate the effect of an exercise program based on the Empowerment Model for participants with heart failure.
This randomized, controlled study including pre-test/post-test and the measurements were performed between January-November 2014 at a university hospital in Izmir, Turkey. Intervention group (n = 11) and control group (n = 10) participated in the research. The intervention group received 45-60 minute individual training and 12 weeks of individual follow-up. The weekly motivational phone calls structured according to the empowerment model and home visits when necessary were repeated. Patients in the control group did not receive any intervention except for their routine treatment. Data were collected before the education of exercise and after 12 weeks; sociodemographic data questionnaire, pedometer, accelerometer, Berg Balance Scale, HF Empowerment Scale, estimated weekly exercise monitoring form and exercise booklet had been utilised. The SPSS statistical package program was used to analyze the data.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- were aged 60 years or older
- independent
- literate
- able to communicate verbally
- participating voluntarly in the study
Exclusion Criteria:
- were having a diagnosis of psychiatric illness
- a visual or auditory impairment
- previously participated in another exercise program
- any contraindication to exercise (uncontrolled arrhythmia, hypertension and metabolic illness, ejection fraction)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Exercise Group
The intervention group received 45-60 minute of individual training and a handbook for the exercise program was given.
These patients were followed for a total of 12 weeks.
The exercise program was developed by reviewing the literature part on physical activity for senior citizens with heart failure.
Education program based on Empowerment model.
Weekly motivational telephone interviews were conducted with the patients, and the home visits and telephone interviews were repeated when belived necessary.
The purpose of the study were explained to all individuals involved in the study.
Body movements, balance levels, exercise durations, and strengths of individuals before exercise program and after exercise program were evaluated.
A booklet demonstrating the exercises was given to the patients to enhance their understanding, and they were allowed to ask questions about the exercise program during the training.
|
The intervention group received 45-60 minute of individual training and a handbook for the exercise program was given.
These patients were followed for a total of 12 weeks.
The weekly motivational phone calls structured according to the empowerment model and home visits when necessary were repeated.
The exercise program was developed by reviewing the literature part on physical activity for senior citizens with heart failure.
The program was established on evidence-based recommendations for the cardiac rehabilitation of patients with HF.
Each session included warm-up and cool-down exercises, moderate walking, and balance exercises.
Andre navn:
|
Ingen inngripen: Control Group
The patients in the control group continued their standard treatment and care.
Data collection forms were applied to the patients in the control group at the first month and 12 weeks after discharge.
After the study was completed, all patients in the control group were provided with home-based exercise training booklets.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Group (empowerment evaluation scale assessment)
Tidsramme: 3 months
|
Old patients were observed and evaluated daily activities during 12 weeks.
The exercise program was established on evidence-based recommendations for patients with Heart Failure (HF).
Empowerment level of individuals before and after exercise program were evaluated.
Empowerment is a model aiming to protect patients' rights and develop the quality of care.
This model is aimed at giving individuals a feeling of success and improving their self image, and is intended to make necessary lifestyle changes easier and more lasting.
Subscales of the empowerment are "Managing the Psychosocial Aspects of Heart Failure", "Assessing Dissatisfaction and Readiness to Change" and "Setting and Achieving Heart Failure Goals".
The Scale evaluated has 28 items and five-way likert-type.
Scores range from 28 to 140, scores of 28-65 classified as low, 66-103 as medium, and 104-140 as high.
|
3 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Control Group (empowerment evaluation scale assessment)
Tidsramme: 3 months
|
The patients in the control group continued their routine treatment and daily living activities.
These patients were observed and evaluated daily activities during 12 weeks.
Empowerment level of the individuals before and after 12 weeks were evaluated.
Empowerment is a model aiming to protect patients' rights and develop the quality of care.
This model is aimed at giving individuals a feeling of success and improving their self image, and is intended to make necessary lifestyle changes easier and more lasting.
Subscales of the empowerment are "Managing the Psychosocial Aspects of Heart Failure", "Assessing Dissatisfaction and Readiness to Change" and "Setting and Achieving Heart Failure Goals".
The Scale evaluated has 28 items and five-way likert-type.
Scores range from 28 to 140, scores of 28-65 classified as low, 66-103 as medium, and 104-140 as high.
|
3 months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Studieleder: Zehra Çiçek FADILOĞLU, Emertus, Ege University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 12-9/7
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Hjertefeil
-
Region SkanePåmelding etter invitasjonHjertesvikt New York Heart Association (NYHA) klasse II | Hjertesvikt New York Heart Association (NYHA) klasse IIISverige
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan... og andre samarbeidspartnereHar ikke rekruttert ennåHjertesvikt, systolisk | Hjertesvikt med redusert utkastningsfraksjon | Hjertesvikt New York Heart Association Klasse IV | Hjertesvikt New York Heart Association klasse IIIPolen
-
Luigi Sacco University HospitalIRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Padova; Università degli Studi di Ferrara og andre samarbeidspartnereRekrutteringAtrieflimmer | Block Complete HeartItalia, Belgia, Sveits
-
University of WashingtonAmerican Heart AssociationFullførtHjertesvikt, Kongestiv | Mitokondriell endring | Hjertesvikt New York Heart Association Klasse IVForente stater
-
Novartis PharmaceuticalsFullførtPasienter som har fullført den 12-måneders behandlingsperioden i kjernestudien (de Novo Heart-mottakere) som var interessert i å bli behandlet med EC-MPS
-
University Hospital, GasthuisbergUkjentTransient Left Ventricular Ballooning SyndromeBelgia
-
NYU Langone HealthRekrutteringTako-tsubo kardiomyopati | Takotsubo kardiomyopati | Broken Heart SyndromeForente stater
-
French Cardiology SocietyFullført
Kliniske studier på Exercise Group
-
Shengjing HospitalRekruttering
-
Boston Medical CenterNational Institute of Mental Health (NIMH)FullførtPosttraumatisk stresslidelseForente stater
-
Hui-Hsun ChiangFullførtUtdanningsproblemer | Sykepleie | Vold på arbeidsplassenTaiwan
-
Ayşegül İşler DalgıçHorizonHar ikke rekruttert ennåStress, følelsesmessig | Helserisikoatferd | Helserelatert atferd | Sunn livsstil | Mangel på fysisk aktivitet | Sunn ernæring | Indeks for sunt kosthold | Ikke-smittsomme sykdommerTyrkia
-
Al-Azhar UniversityFullførtKlasse II feilslutningEgypt
-
RenJi HospitalHar ikke rekruttert ennåVæskerespons | Slagvolumvariasjon | SVV-FloTrac | Thorax elektrisk bioimpedansKina
-
RenJi HospitalHar ikke rekruttert ennåVæskerespons | Slagvolumvariasjon | SVV-FloTrac | Thorax elektrisk bioimpedansKina
-
AdventHealthAdventist UniversityFullførtSvimmelhetForente stater
-
IR Technology, LLCFullførtOvervekt | Kroppsvekt | Cellulitt | Fettbrenning | Magefett | FettvevsatrofiForente stater
-
Community Health Center of Franklin CountyMassachusetts General Hospital; Just RootsUkjent